Predictive biomarkers for response to omalizumab in patients with severe allergic asthma: a meta-analysis.
Expert review of respiratory medicine（2022）
摘要
Pre-treatment blood eosinophil counts and total serum IgE level can be a useful efficacy predictor in selecting allergic asthma patients for omalizumab treatment.
更多查看译文
关键词
Omalizumab,allergic severe asthma,biomarker,meta-analysis
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要